We have located links that may give you full text access.
Protein-engineered microenvironments can promote endothelial differentiation of human mesenchymal stem cells in the absence of exogenous growth factors.
Biomaterials Science 2016 November 16
Peripheral artery disease often requires treatments with vascular grafts for vessel reconstruction. Endothelialization of the vascular grafts is important to achieve long-term patency because endothelial cells regulate thrombosis, inflammation, and growth of smooth muscle cells. One potential source of endothelial cells is human mesenchymal stem cells (hMSCs), which can be routinely differentiated towards the endothelial lineage using exogenous growth factors such as vascular endothelial growth factor (VEGF). However, there are few studies that investigate the effect of materials on endothelial differentiation in the absence of growth factors. This study demonstrates that exogenous growth factors are not needed to achieve endothelial differentiation of hMSCs and that protein-based microenvironments promote endothelial differentiation. Specifically, we genetically engineered proteins containing a VEGF-mimicking peptide and resilin repeats and demonstrated that cells grown on the protein-engineered microenvironments were viable, had normal metabolic activity, and displayed increased endothelial-specific markers and endothelial function compared to negative control cells. In particular, cells cultured on our proteins formed networks that were statistically equivalent to positive control cells. We confirmed that the mere presence of protein on surfaces was insufficient to promote endothelial differentiation of hMSCs, and the specific composition of the RZ-QK protein appeared to be necessary for promoting differentiation. Thus, our protein-based materials are promising tools for obtaining endothelial cells for use in vascular grafts.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app